Groundbreaking Cell Therapy NRTX-1001 Promises Over 90% Seizure Reduction: A New Hope for Drug-Resistant Epilepsy Patients Read More »
RoslinCT and Lykan Bioscience: The Dynamic Duo Redefining the Future of Cell and Gene Therapy Read More »
